Found 19 matching trials
A Study of Recombinant Vaccinia Virus in Combination With Cemiplimab for Renal Cell Carcinoma
PHASE1This is a Phase 1b/2a, open-label, multi-center, dose-escalation and safety...
Location
Site 2644 University of California, Irvine
Neoadjuvant Study of Recombinant Vaccinia Virus to Treat Metastatic Colorectal Carcinoma in Patients Undergoing Complete Resection of Liver Tumors
PHASE2This is a neoadjuvant Phase 2a, open-label trial in patients with metastati...
Location
Ottawa Hospital and Research Institute (OHRI)
Phase 2 Study of JX-594 in Patients With Peritoneal Carcinomatosis of Ovarian Cancer Origin
PHASE2This is a single-arm open-label Phase 2 study in patients with peritoneal c...
Location
Princess Margaret Cancer Center
Safety Study of Recombinant Vaccinia Virus to Treat Refractory Solid Tumors
PHASE1This is a Phase I, open-label, dose-escalation trial in patients with advan...
A Phase 2a Study of Modified Vaccinia Virus to Treat Sorafenib-naïve Advanced Liver Cancer
PHASE2This study is to determine how effectively JX-594 (Pexa-Vec) will prolong l...
A Phase 2b Study of Modified Vaccinia Virus to Treat Patients Advanced Liver Cancer Who Failed Sorafenib
PHASE2This study is to determine whether JX-594 (Pexa-Vec) plus best supportive c...
Location
Moores University of California San Diego Cancer Center
Recombinant Vaccinia Virus Administered Intravenously in Patients With Metastatic, Refractory Colorectal Carcinoma
PHASE1The purpose of this study is to evaluate the safety, tolerability, and effi...
A Phase I Clinical Study of Intratumoral Injection GC001 in Patient With Recurrent or Progressive Gliomas
PHASE1A Phase I Study Evaluating the Safety, Tolerability, Biodistribution and Sh...
Location
Beijing Tiantan Hospital,Capital Medical University
A Phase I Clinical Study of Intratumoral Injection Oncolytic Vaccinia Virus GC001 in Patient With Advanced Solid Tumors
PHASE1The present trial is an open, single-arm phase I clinical study aimed at as...
Location
Henan Cancer Hospital
A Study of Pexa-Vec (JX-594) Prior to Sorafenib to Treat Unresectable Primary Hepatocellular Carcinoma
PHASE2The purpose of this pilot safety study is to evaluate the safety and tolera...
Location
Pusan National University Hospital